Page last updated: 2024-09-02

carboxyamido-triazole and Cancer of Kidney

carboxyamido-triazole has been researched along with Cancer of Kidney in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hollis, D; Mahoney, J; Ratain, MJ; Rini, B; Rosner, G; Small, E; Stadler, WM; Zaentz, SD1
Dutcher, JP; Friedland, DM; Leon, L; Manola, J; Roth, B; Wilding, G1

Trials

2 trial(s) available for carboxyamido-triazole and Cancer of Kidney

ArticleYear
Successful implementation of the randomized discontinuation trial design: an application to the study of the putative antiangiogenic agent carboxyaminoimidazole in renal cell carcinoma--CALGB 69901.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Jun-01, Volume: 23, Issue:16

    Topics: Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antineoplastic Agents; Carcinoma, Renal Cell; Disease-Free Survival; Double-Blind Method; Female; Humans; Kidney Neoplasms; Male; Middle Aged; Neovascularization, Pathologic; Research Design; Survival Rate; Treatment Outcome; Triazoles

2005
Phase II study of carboxyamidotriazole in patients with advanced renal cell carcinoma refractory to immunotherapy: E4896, an Eastern Cooperative Oncology Group Study.
    Cancer, 2005, Dec-01, Volume: 104, Issue:11

    Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Renal Cell; Disease Progression; Female; Humans; Kidney Neoplasms; Male; Middle Aged; Patient Selection; Time Factors; Treatment Outcome; Triazoles

2005